Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Leukemia

Free Subscription Articles published in Bone Marrow Transplant Retrieve available abstracts of 58 articles: HTML format Text format

Single Articles

December 2011
1. HUANG J , Zou DH, Li ZJ, Fu MW, et al
   An auto-SCT-based total therapy resulted in encouraging outcomes in adolescents and young adults with acute lymphoblastic leukemia: report from a single center of China.
   Bone Marrow Transplant. 2011 Dec 19. doi: 10.1038/bmt.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
2. WANG Y , Liu DH, Xu LP, Liu KY, et al
   Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis.
   Bone Marrow Transplant. 2011 Nov 7. doi: 10.1038/bmt.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
3. CHIUSOLO P , Metafuni E, Bellesi S, Giammarco S, et al
   Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia.
   Bone Marrow Transplant. 2011 Sep 19. doi: 10.1038/bmt.2011.
   PubMed     Text format     Related articles   
   
   
   
   
4. MOHTY M
   Adult acute lymphocytic leukemia: biology and treatment.
   Bone Marrow Transplant. 2011;46:1282.
   PubMed     Text format     Related articles   
   
   
   
   August 2011
5. KANDA Y , Sakamoto K, Ashizawa M, Sato M, et al
   Risks and benefits of ovarian shielding in female patients undergoing TBI: a decision analysis.
   Bone Marrow Transplant. 2011;46:1145-7.
   PubMed     Text format     Related articles   
   
   
   
   July 2011
6. BOKHARI SW , Watson L, Nagra S, Cook M, et al
   Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantatio
   Bone Marrow Transplant. 2011 Jul 11. doi: 10.1038/bmt.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. CHENG H , Kirtani VG, Gergis U
   Current status of allogeneic HST for chronic myelomonocytic leukemia.
   Bone Marrow Transplant. 2011 Jul 11. doi: 10.1038/bmt.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. HE X , Wu D, Sun A
   Extramedullary relapse following allogeneic BMT in a postpartum female patient with acute lymphoblastic leukemia.
   Bone Marrow Transplant. 2011 Jul 4. doi: 10.1038/bmt.2011.
   PubMed     Text format     Related articles   
   
   
   
   June 2011
9. ZHAO XS , Jin S, Zhu HH, Xu LP, et al
   Wilms' tumor gene 1 expression: an independent acute leukemia prognostic indicator following allogeneic hematopoietic SCT.
   Bone Marrow Transplant. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. WIRK B
    Renal failure in multiple myeloma: a medical emergency.
    Bone Marrow Transplant. 2011;46:771-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. SHARMA S , Yang S, Rochester R, Britton L, et al
    Prevalence of osteonecrosis and associated risk factors in children before allogeneic BMT.
    Bone Marrow Transplant. 2011;46:813-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
12. METAXAS Y , Bertz H, Spyridonidis A, Spyroupoulou-Vlachou M, et al
    CT60 single-nucleotide polymorphism as a surrogate marker for donor lymphocyte infusion outcome after allogeneic cell transplantation for acute leukemia.
    Bone Marrow Transplant. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. MARTINO R , Kerguelen A, Valcarcel D, Sureda A, et al
    Reduction of infection-related mortality after allogeneic PBSCT from HLA-identical siblings: longitudinal analysis from 1994 to 2008 at a single institution.
    Bone Marrow Transplant. 2011;46:690-701.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. PIDALA J , Kim J, Anasetti C, Kharfan-Dabaja MA, et al
    Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicity.
    Bone Marrow Transplant. 2011;46:641-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. CUTLER C , Stevenson K, Kim HT, Brown J, et al
    Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis.
    Bone Marrow Transplant. 2011;46:659-67.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. O'MEARA A , Pabst T, Heim D, Gerull S, et al
    High-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AML.
    Bone Marrow Transplant. 2011;46:636-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. ALSULTAN A , Giller RH, Gao D, Bathurst J, et al
    GVHD after unrelated cord blood transplant in children: characteristics, severity, risk factors and influence on outcome.
    Bone Marrow Transplant. 2011;46:668-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. ELMAAGACLI AH , Steckel N, Ditschkowski M, Hegerfeldt Y, et al
    Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donors.
    Bone Marrow Transplant. 2011;46:702-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
19. MAHINDRA A , Bolwell BJ, Rybicki L, Elder P, et al
    Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia.
    Bone Marrow Transplant. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. KHABORI MA , El-Emary M, Xu W, Guyatt G, et al
    Impact of intensity of conditioning therapy in patients aged 40-60 years with AML/myelodysplastic syndrome undergoing allogeneic transplantation.
    Bone Marrow Transplant. 2011;46:516-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. MASUOKA K , Uchida N, Ishiwata K, Takagi S, et al
    What is the upper age limit for performing allo-SCT? Cord blood transplantation for an 82-year-old patient with AML.
    Bone Marrow Transplant. 2011;46:619-20.
    PubMed     Text format     Related articles   
    
    
    
    
22. KRAUTER J , Wagner K, Stadler M, Dammann E, et al
    Prognostic factors in allo-SCT of elderly patients with AML.
    Bone Marrow Transplant. 2011;46:545-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
23. CHALAYER E , Tavernier-Tardy E, Clavreul G, Bay JO, et al
    Carcinomatosis lymphangitis and pleurisy after allo-SCT in two patients with secondary leukemia after breast cancer.
    Bone Marrow Transplant. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
24. LINKER C , Damon L, Martin T, Blume K, et al
    Autologous hematopoietic cell transplantation for high-risk ALL.
    Bone Marrow Transplant. 2011;46:460-1.
    PubMed     Text format     Related articles   
    
    
    
    
25. RUBIN J , Vettenranta K, Vettenranta J, Bierings M, et al
    Use of intrathecal chemoprophylaxis in children after SCT and the risk of central nervous system relapse.
    Bone Marrow Transplant. 2011;46:372-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. MAJHAIL NS , Bajorunaite R, Lazarus HM, Wang Z, et al
    High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR.
    Bone Marrow Transplant. 2011;46:385-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
27. JABBOUR M , Tuncer H, Castillo J, Butera J, et al
    Hematopoietic SCT for adult T-cell leukemia/lymphoma: a review.
    Bone Marrow Transplant. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
28. MEGURO A , Ozaki K, Hatanaka K, Oh I, et al
    Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cells.
    Bone Marrow Transplant. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. CHEUK DK
    Inherent problems of comparing second and third remission in patients with acute lymphoblastic leukemia.
    Bone Marrow Transplant. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
30. UBERTI JP , Agovi MA, Tarima S, Haagenson M, et al
    Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia.
    Bone Marrow Transplant. 2011;46:34-43.
    PubMed     Text format     Related articles   
    
    
    
    
31. TACHIBANA T , Takasaki H, Tanaka M, Maruta A, et al
    Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome.
    Bone Marrow Transplant. 2011;46:150-1.
    PubMed     Text format     Related articles   
    
    
    
    
32. SCHUB N , Gunther A, Schrauder A, Claviez A, et al
    Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective.
    Bone Marrow Transplant. 2011;46:143-7.
    PubMed     Text format     Related articles   
    
    
    
    
33. CANTONI N , Weisser M, Frei R, Lardinois D, et al
    Black hole in the lung.
    Bone Marrow Transplant. 2011;46:154-5.
    PubMed     Text format     Related articles   
    
    
    
    
34. VERDEGUER A , de Heredia CD, Gonzalez M, Martinez AM, et al
    Observational prospective study of viral infections in children undergoing allogeneic hematopoietic cell transplantation: a 3-year GETMON experience.
    Bone Marrow Transplant. 2011;46:119-24.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
35. SPYRIDONIDIS A , Liga M, Triantafyllou E, Themeli M, et al
    Pharmacokinetics and clinical activity of very low-dose alemtuzumab in transplantation for acute leukemia.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. STEIN AS , O'Donnell MR, Synold TW, Dagis AC, et al
    Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
37. VENEPALLI N , Rezvani K, Mielke S, Savani BN, et al
    Role of allo-SCT for CML in 2010.
    Bone Marrow Transplant. 2010;45:1579-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. ARMAND P , Kim HT, Mayer E, Cutler CS, et al
    Outcome of allo-SCT for women with MDS or AML occurring after breast cancer therapy.
    Bone Marrow Transplant. 2010;45:1611-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. LISSANDRE S , Bay JO, Cahn JY, Porcher R, et al
    Retrospective study of allogeneic haematopoietic stem-cell transplantation for myelofibrosis.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
40. ROZOVSKI U , Herishanu Y, Gipstein L, Naparstek E, et al
    Fatal H1N1 influenza infection in an allo-SCT recipient.
    Bone Marrow Transplant. 2010;45:1572-3.
    PubMed     Text format     Related articles   
    
    
    
    
41. KRISHNAMURTHY P , Lim ZY, Nagi W, Kenyon M, et al
    Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience.
    Bone Marrow Transplant. 2010;45:1502-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
42. YABE M , Morimoto T, Shimizu T, Koike T, et al
    Therapy-related myelodysplastic syndrome of recipient origin in a juvenile myelomonocytic leukemia patient 17 years after allogeneic BMT.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
43. BECK JC , Cao Q, Trotz B, Smith AR, et al
    Allogeneic hematopoietic cell transplantation outcomes for children with B-precursor acute lymphoblastic leukemia and early or late BM relapse.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. KAMIMURA T , Miyamoto T, Nagafuji K, Numata A, et al
    Role of autotransplantation in the treatment of acute promyelocytic leukemia patients in remission: Fukuoka BMT Group observations and a literature review.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
45. NISHIZAWA M , Sugino N, Matsui Y, Kaneko H, et al
    Sustained CR of refractory aggressive natural killer cell leukemia following unrelated cord blood transplantation.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
46. DENZ U , Bertz H, Ihorst G, Wasch R, et al
    Improved outcome in relapsed and refractory myeloid malignancies for unrelated vs related donor allogeneic peripheral blood-derived hematopoietic cell transplantation.
    Bone Marrow Transplant. 2010;45:1309-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. HSIAO HH , Tsai HJ, Liu YC, Lee CP, et al
    Allo-SCT in a rare t(8;21) evolution of CML.
    Bone Marrow Transplant. 2010;45:1365-6.
    PubMed     Text format     Related articles   
    
    
    
    July 2010
48. MAERTENS J , Marchetti O, Herbrecht R, Cornely OA, et al
    European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3-2009 Update.
    Bone Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. COURBIERE B , Prebet T, Mozziconacci MJ, Metzler-Guillemain C, et al
    Tumor cell contamination in ovarian tissue cryopreserved before gonadotoxic treatment: should we systematically exclude ovarian autograft in a cancer survivor?
    Bone Marrow Transplant. 2010;45:1247-8.
    PubMed     Text format     Related articles   
    
    
    
    June 2010
50. LINN YC , Phang CY, Lim TJ, Chong SF, et al
    Effect of missing killer-immunoglobulin-like receptor ligand in recipients undergoing HLA full matched, non-T-depleted sibling donor transplantation: a single institution experience of 151 Asian patients.
    Bone Marrow Transplant. 2010;45:1031-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. YOON SR , Lee YS, Yang SH, Ahn KH, et al
    Generation of donor natural killer cells from CD34(+) progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study.
    Bone Marrow Transplant. 2010;45:1038-46.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. CONCHON M , Sanabani SS, Bendit I, Serpa M, et al
    Achievement of complete donor-type chimerism and remission with dasatinib in Philadelphia chromosome-positive ALL relapsing after allogeneic transplantation.
    Bone Marrow Transplant. 2010;45:1125-6.
    PubMed     Text format     Related articles   
    
    
    
    
53. GIEBEL S , Stella-Holowiecka B, Krawczyk-Kulis M, Gokbuget N, et al
    Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL.
    Bone Marrow Transplant. 2010;45:1095-101.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. BUSEMANN C , Schuler F, Kruger W, Kiefer T, et al
    Late extramedullary relapse after allogeneic transplantation in a case of variant hairy cell leukaemia.
    Bone Marrow Transplant. 2010;45:1117-8.
    PubMed     Text format     Related articles   
    
    
    
    April 2010
55. LEMOLI RM , D'Addio A, Marotta G, Pezzullo L, et al
    BU/melphalan and auto-SCT in AML patients in first CR: a 'Gruppo Italiano Trapianto di Midollo Osseo (GITMO)' retrospective study.
    Bone Marrow Transplant. 2010;45:640-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. LIM ZY , Ingram W, Brand R, Ho A, et al
    Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML.
    Bone Marrow Transplant. 2010;45:633-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2009
57. PATIL S , Spencer A, Schwarer A, Lewis I, et al
    Reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation results in durable disease-free and overall survival in patients with poor prognosis myeloid and lymphoid malignancies: eighty-month follow-up.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2009
58. ADES L , Eclache V, Gardin C, Boehrer S, et al
    Efficacy of lenalidomide in an sAML patient with del 5q relapsing after reduced-intensity allogeneic stem cell transplantation performed in complete remission.
    Bone Marrow Transplant. 2009.
    PubMed     Text format     Related articles   
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: